Uncertainty over Research and Development Investment Outcomes
First written in FY2016. 5 of 7 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.
5 other companies' latest entry also says "Mitigated".
- FY2024MitigatedAnnual report
「In addition to conducting regular monitoring of each research and development project, the Group is working to maximize the use of research and development data accumulated by Group companies through technical exchanges within the Group and other measures.」
To address the uncertainty surrounding research and development results, the company has identified regular project-level monitoring and technical exchanges and data use within the Group as measures. - FY2022RestatedAnnual report
「The results are uncertain, and the Group faces the risk that even substantial expenditure may not necessarily lead to results. In particular, if research and development investment in new products and technologies fails to generate sufficient returns in the future, or if data accumulated within the Group cannot be used in the development of new products and technologies, there is concern that the Group's future growth and profitability could decline.」
In addition to the uncertainty surrounding the results of research and development investment, the company explicitly identifies the risk that accumulated data cannot be used for new products and technologies. - FY2019-Q3RestatedAnnual report
「The amount spent on R&D activities across the group during the first nine months of the current consolidated fiscal year was ¥10,305 million. There were no material changes in the status of the group’s R&D activities during the first nine months of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities, and indicates no new changes in its disclosures concerning uncertainty over the results of research and development investment. - FY2019-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current fiscal year was ¥3.297 billion. There were no material changes in the status of the Group's research and development activities during the first quarter of the current fiscal year.」
Research and development expenditure for the first quarter was ¥3.297 billion, and the company states that there were no material changes in its research and development activities. - FY2018RestatedAnnual report
「The results are uncertain, and the Group faces the risk that even substantial expenditure may not necessarily lead to results.」
The company continues to disclose the uncertainty surrounding the results of research and development investment. - FY2017RestatedAnnual report
「The results are uncertain, and the Group faces the risk that even substantial expenditure may not necessarily lead to results.」
The company continues to indicate that research and development investment may not translate into future growth or profitability. - FY2016First statedAnnual report
「The Group faces the risk that even substantial expenditure may not necessarily lead to results.」
The company indicates that research and development investment may not translate into future growth or profitability.